These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3277517)

  • 21. [Arrhythmia and anti-arrhythmia therapy as prognostic risks].
    Meinertz T; Zehender M; Hofmann T; Hohnloser S; Just H
    Herz; 1991 Sep; 16 Spec No 1():314-7, 323. PubMed ID: 1820298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risks and rules in the use of anti-arrhythmia agents].
    Motté G; Sebag C
    Arch Mal Coeur Vaiss; 1981 Apr; 74(4):473-9. PubMed ID: 6786244
    [No Abstract]   [Full Text] [Related]  

  • 23. Ventricular arrhythmia induction study.
    Freedman RA; Mason JW
    Cardiovasc Clin; 1985; 15(1):215-29. PubMed ID: 3842328
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of serious cardiac arrhythmias with drugs.
    Echt DS; Mason JW
    Cardiovasc Clin; 1984; 14(3):191-209. PubMed ID: 6426796
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-arrhythmia agents and sudden death].
    Correia MJ
    Rev Port Cardiol; 1992 Apr; 11(4):391-6. PubMed ID: 1632997
    [No Abstract]   [Full Text] [Related]  

  • 26. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 27. Long term management of ventricular arrhythmias--to treat or not to treat?
    Talajic M
    Can J Cardiol; 1991 Mar; 7(2):96-7; discussion 103-4. PubMed ID: 2049689
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiarrhythmic therapy for asymptomatic ventricular arrhythmias.
    Prystowsky EN
    Am J Cardiol; 1988 Jan; 61(2):102A-107A. PubMed ID: 3276121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiarrhythmic drug therapy and prevention of cardiac emergencies in the prehospital phase].
    von Knorre GH
    Z Arztl Fortbild (Jena); 1984; 78(15):621-2. PubMed ID: 6495771
    [No Abstract]   [Full Text] [Related]  

  • 31. Tachyarrhythmias in Wolff-Parkinson-White syndrome. Antiarrhythmic drug therapy.
    Chung EK
    JAMA; 1977 Jan; 237(4):376-9. PubMed ID: 576173
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of cardiac arrhythmias.
    Han J
    Am Fam Physician; 1976 Jan; 13(1):128-38. PubMed ID: 1251787
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical approach to antiarrhythmic therapy in patients with ventricular arrhythmia.
    Reddy CP; Arnett JD
    J La State Med Soc; 1989 May; 141(5):45-8. PubMed ID: 2659710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dangers of and indications for anti-arrhythmia therapy in the aged].
    Follath F
    Fortschr Med; 1983 Sep; 101(33):1460-4. PubMed ID: 6629271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abolishing advanced grades of ventricular premature beats protects patients with recurring malignant ventricular arrhythmias.
    Lown B; Graboys TB
    Int J Cardiol; 1983 Oct; 4(3):345-50. PubMed ID: 6642767
    [No Abstract]   [Full Text] [Related]  

  • 36. Problems of antiarrhythmic treatment in children.
    Coumel P; Fidelle J
    Cardiologia; 1983 Sep; 28(9):767-82. PubMed ID: 6687332
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of asymptomatic ventricular dysrhythmia in patients with ischemic heart disease.
    Rosen KM; Swiryn SP; Palileo EA; Strasberg B
    Arch Intern Med; 1980 Nov; 140(11):1419-21. PubMed ID: 6159831
    [No Abstract]   [Full Text] [Related]  

  • 38. Ventricular arrhythmias, Part III: Benefits and risks of antiarrhythmic therapy.
    Grauer K; Gums J
    J Am Board Fam Pract; 1988; 1(4):255-66. PubMed ID: 3066124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ; Blatt CM
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic activity of the hydrochloride of 1-methoxymethyl-2-(1-perhydroazepinyl)ethyl ester of 2-(n)-pentyloxycarbanilic acid.
    Gibala P; Sotníková R; Knezl V; Drímal J
    Arzneimittelforschung; 1987 Feb; 37(2):149-52. PubMed ID: 3580018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.